Free Trial

Bioceres Crop Solutions (BIOX) Earnings Date, Estimates & Call Transcripts

Bioceres Crop Solutions logo
$6.89 -0.02 (-0.29%)
As of 01/17/2025 04:00 PM Eastern

Bioceres Crop Solutions Latest Earnings Summary

Upcoming Q2
Earnings Date
Feb. 13Before Market OpensEstimated
Actual EPS
(Nov. 11)
-$0.09 Missed By -$0.11
Consensus EPS
(Nov. 11)
$0.02

Bioceres Crop Solutions issued Q1 2025 earnings on November 11, 2024, reporting an EPS of -$0.09, which missed analysts' consensus estimates of $0.02 by $0.11. Quarterly revenue was reported to be $92.60 million, below the consensus estimate of $117.15 million. With a trailing EPS of $0.02 and a P/E Ratio of 344.67, Bioceres Crop Solutions' earnings are expected to grow 283.33% next year, from $0.12 to $0.46 per share.

BIOX Upcoming Earnings

Bioceres Crop Solutions' next earnings date is estimated for Thursday, February 13, 2025, based off prior year's reporting schedules.

Get Bioceres Crop Solutions Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bioceres Crop Solutions and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BIOX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BIOX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Bioceres Crop Solutions Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252$0.04$0.09$0.07
Q2 20252$0.09$0.14$0.12
Q3 20252-$0.01$0.02$0.01
Q4 20252$0.09$0.13$0.11
FY 20258$0.21$0.38$0.30

Bioceres Crop Solutions Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
2/13/2025
(Estimated)
-------
11/11/2024Q1 2025$0.02-$0.09 -$0.11-$0.09$117.15M$92.60M
9/9/2024Q4 2024$0.1950-$0.03 -$0.2250-$0.03$126.75M$124.30M
5/29/2024Q3 2024$0.16$0.14 -$0.02$0.14$88.80M$83.98M
2/8/2024Q4 2023$0.07$0.09+$0.02-$108.97M$140.30M
11/13/2023Q1 2024$0.11-$0.07 -$0.18-$0.07$131.53M$116.60M
9/11/2023Q2 2023$0.04-$0.06 -$0.10-$0.06$96.59M$104.70M
5/10/2023Q3 2023-$0.02$0.45+$0.47$0.45$78.98M$93.61M
2/8/2023Q2 2023$0.16-$0.14 -$0.30-$0.14$106.90M$94.41M

Bioceres Crop Solutions Earnings - Frequently Asked Questions

Bioceres Crop Solutions has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based off last year's report dates. Learn more on BIOX's earnings history.

In the previous quarter, Bioceres Crop Solutions (NASDAQ:BIOX) missed the analysts' consensus estimate of $0.02 by $0.11 with a reported earnings per share (EPS) of ($0.09). Learn more on analysts' earnings estimate vs. BIOX's actual earnings.

The conference call for Bioceres Crop Solutions's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Bioceres Crop Solutions's latest earnings report can be read online.
Read Transcript

Bioceres Crop Solutions (NASDAQ:BIOX) has a recorded annual revenue of $464.80 million.

Bioceres Crop Solutions (NASDAQ:BIOX) has a recorded net income of $3.24 million. BIOX has generated $0.02 earnings per share over the last four quarters.

Bioceres Crop Solutions (NASDAQ:BIOX) has a trailing price-to-earnings ratio of 344.67 and a forward price-to-earnings ratio of 57.42.

Bioceres Crop Solutions's earnings are expected to grow from $0.12 per share to $0.46 per share in the next year, which is a 283.33% increase.

More Earnings Resources from MarketBeat



This page (NASDAQ:BIOX) was last updated on 1/18/2025 by MarketBeat.com Staff
From Our Partners